Research location
Mosdós
Hungary
Advertisement
Research activity in Mosdós
HungaryCureCurrent currently publishes aggregate city-level research activity for this location: 24 trials and 24 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mosdós
24 linked trials · page 1 of 1A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaNCT02554786 · 2015-12-29 · 1 site observation
COMPLETED
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaNCT02139644 · 2014-06-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaNCT02141854 · 2014-06-01 · 1 site observation
COMPLETED
Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®NCT01803555 · 2013-07-04 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsNCT01479621 · 2012-01-01 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate AsthmaNCT01383499 · 2011-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent AsthmaNCT01277523 · 2011-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent AsthmaNCT01257230 · 2010-12-01 · 1 site observation
COMPLETED
Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLCNCT01203917 · 2010-09-01 · 1 site observation
COMPLETED
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment AdherenceNCT01081509 · 2010-03-01 · 1 site observation
COMPLETED
AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC PatientsNCT00890825 · 2009-04-20 · 1 site observation
COMPLETED
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.NCT00563381 · 2008-01-01 · 1 site observation
COMPLETED
Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active ControlNCT00393458 · 2006-10-01 · 1 site observation
COMPLETED
A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With AsthmaNCT00384189 · 2006-09-01 · 1 site observation
COMPLETED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)NCT00297102 · 2006-02-01 · 1 site observation
COMPLETED
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.NCT00269828 · 2005-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)NCT00163449 · 2005-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)NCT00163436 · 2005-09-01 · 1 site observation
COMPLETED
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCNCT00291850 · 2005-06-01 · 1 site observation
TERMINATED
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDNCT00206167 · 2005-04-01 · 1 site observation
COMPLETED
Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)NCT00102804 · 2005-03-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT00806923 · 2005-02-01 · 1 site observation
COMPLETED
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)NCT00163462 · 2004-10-01 · 1 site observation
COMPLETED
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further TreatmentNCT00683306 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.